Report cover image

Immunovia AB (IMMNOV) - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Feb 16, 2026
Length 37 Pages
SKU # GBDT20881295

Description

Summary

Immunovia AB (Immunovia) is a diagnostic company that focuses on the early detection of pancreatic cancer through advanced blood-based testing. The company provides clinical diagnostic testing services and works closely with healthcare providers, researchers, and payers to support early cancer detection, clinical validation, and reimbursement pathways. Immunovia’s product is PancreaSure, a next-generation blood test for the early detection of pancreatic ductal adenocarcinoma (PDAC). The company serves high-risk individuals for pancreatic cancer, healthcare professionals, clinical institutions, and the broader oncology diagnostics market. It operates in the life sciences and medical diagnostics sector. Immunovia is headquartered in Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Immunovia AB
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

37 Pages
Immunovia AB Company Overview
Immunovia AB Company Snapshot
Immunovia AB Pipeline Products and Ongoing Clinical Trials Overview
Immunovia AB – Pipeline Analysis Overview
Immunovia AB - Key Facts
Immunovia AB - Major Products and Services
Immunovia AB Pipeline Products by Development Stage
Immunovia AB Ongoing Clinical Trials by Trial Status
Immunovia AB Pipeline Products Overview
IMMray - Breast Cancer
IMMray - Breast Cancer Product Overview
IMMray - NSCLC
IMMray - NSCLC Product Overview
IMMray - Prostate Cancer
IMMray - Prostate Cancer Product Overview
IMMray PanCan-d
IMMray PanCan-d Product Overview
IMMray PanCan-d Clinical Trial
IMMray PanCan-m Test
IMMray PanCan-m Test Product Overview
IMMray Primary Sjogren’s Syndrome Assay
IMMray Primary Sjogren’s Syndrome Assay Product Overview
IMMray Rheumatoid Arthritis Assay
IMMray Rheumatoid Arthritis Assay Product Overview
IMMray SLE-d Test
IMMray SLE-d Test Product Overview
IMMray Systemic Vasculitis Assay
IMMray Systemic Vasculitis Assay Product Overview
PancreaSure
PancreaSure Product Overview
PancreaSure Clinical Trial
ProMIS Assay
ProMIS Assay Product Overview
Immunovia AB - Key Competitors
Immunovia AB - Key Employees
Immunovia AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Immunovia AB, Recent Developments
Jan 23, 2026: Immunovia attends Aktiespararna Life Science
Jan 19, 2026: Immunovia receives state regulatory approval for PancreaSure in California and initiates commercial rollout
Dec 22, 2025: Immunovia’s Analytical Validation Study of PancreaSure Published in Diagnostics
Nov 26, 2025: Immunovia Receives Final Medicare Payment Rate for PancreaSure Test
Nov 24, 2025: Immunovia: VERIFI Study Published in Current Oncology
Nov 24, 2025: VERIFI Study Published in Peer-Reviewed Journal Current Oncology
Oct 27, 2025: Immunovia To Present PancreaSure Clinical Validation Data At ACG Annual Meeting
Sep 24, 2025: PancreaSure Demonstrates 88% Sensitivity and 98% Specificity in Interim Analysis of Third Validation Study
Sep 22, 2025: Immunovia Gains Control Over PancreaSure Supply Chain and Reduces Costs Through Licensing Agreement
Sep 11, 2025: Immunovia Receives Preliminary Payment Determination from CMS for PancreaSure Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Immunovia AB Pipeline Products and Ongoing Clinical Trials Overview
Immunovia AB Pipeline Products by Equipment Type
Immunovia AB Pipeline Products by Indication
Immunovia AB Ongoing Clinical Trials by Trial Status
Immunovia AB, Key Facts
Immunovia AB, Major Products and Services
Immunovia AB Number of Pipeline Products by Development Stage
Immunovia AB Pipeline Products Summary by Development Stage
Immunovia AB Ongoing Clinical Trials by Trial Status
Immunovia AB Ongoing Clinical Trials Summary
IMMray - Breast Cancer - Product Status
IMMray - Breast Cancer - Product Description
IMMray - NSCLC - Product Status
IMMray - NSCLC - Product Description
IMMray - Prostate Cancer - Product Status
IMMray - Prostate Cancer - Product Description
IMMray PanCan-d - Product Status
IMMray PanCan-d - Product Description
IMMray PanCan-d - A Prospective Evaluation of IMMray PanCan-d Biomarker Signature Assay in Subjects with New Onset Diabetes (NOD)
IMMray PanCan-d - IMMray PanCan-d Utility in Patients with Abdominal Symptoms Attending Secondary Care Centres
IMMray PanCan-m Test - Product Status
IMMray PanCan-m Test - Product Description
IMMray Primary Sjogren’s Syndrome Assay - Product Status
IMMray Primary Sjogren’s Syndrome Assay - Product Description
IMMray Rheumatoid Arthritis Assay - Product Status
IMMray Rheumatoid Arthritis Assay - Product Description
IMMray SLE-d Test - Product Status
IMMray SLE-d Test - Product Description
IMMray Systemic Vasculitis Assay - Product Status
IMMray Systemic Vasculitis Assay - Product Description
PancreaSure - Product Status
PancreaSure - Product Description
PancreaSure - A Clinical Study to Assess the Effects of Next Generation Pancreatic Cancer Detection Test in the United States
ProMIS Assay - Product Status
ProMIS Assay - Product Description
Immunovia AB, Key Employees
Immunovia AB, Subsidiaries
Glossary
List of Figures
Immunovia AB Pipeline Products by Equipment Type
Immunovia AB Pipeline Products by Development Stage
Immunovia AB Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us